HEADER DE NOVO PROTEIN 10-MAR-04 1SN9 TITLE AN OLIGOMERIC DOMAIN-SWAPPED BETA-BETA-ALPHA MINI-PROTEIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: TETRAMERIC BETA-BETA-ALPHA MINI-PROTEIN; COMPND 3 CHAIN: A, B, C, D; COMPND 4 SYNONYM: BBAT; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 OTHER_DETAILS: THE PROTEIN WAS CHEMICALLY SYNTHESIZED. KEYWDS PROTEIN DESIGN, DOMAIN SWAPPING, MINI-PROTEIN, OLIGOMERIZATION, DE KEYWDS 2 NOVO PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR M.H.ALI,E.PEISACH,K.N.ALLEN,B.IMPERIALI REVDAT 6 03-APR-24 1SN9 1 REMARK REVDAT 5 15-NOV-23 1SN9 1 REMARK LINK ATOM REVDAT 4 24-FEB-09 1SN9 1 VERSN REVDAT 3 26-OCT-04 1SN9 1 MODRES REVDAT 2 24-AUG-04 1SN9 1 JRNL REVDAT 1 17-AUG-04 1SN9 0 JRNL AUTH M.H.ALI,E.PEISACH,K.N.ALLEN,B.IMPERIALI JRNL TITL X-RAY STRUCTURE ANALYSIS OF A DESIGNED OLIGOMERIC JRNL TITL 2 MINIPROTEIN REVEALS A DISCRETE QUATERNARY ARCHITECTURE JRNL REF PROC.NATL.ACAD.SCI.USA V. 101 12183 2004 JRNL REFN ISSN 0027-8424 JRNL PMID 15302930 JRNL DOI 10.1073/PNAS.0401245101 REMARK 2 REMARK 2 RESOLUTION. 1.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 99.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 86.5 REMARK 3 CROSS-VALIDATION METHOD : FREE R REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.190 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.188 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.285 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 10.100 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 1983 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 19671 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.184 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.182 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.278 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 10.100 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 1763 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 17510 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 728 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 118 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 843.50 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 0.00 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 13 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 8097 REMARK 3 NUMBER OF RESTRAINTS : 10728 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.032 REMARK 3 ANGLE DISTANCES (A) : 0.039 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.023 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.056 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.060 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.109 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.003 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.064 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.084 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1SN9 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-MAR-04. REMARK 100 THE DEPOSITION ID IS D_1000021847. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 14-BM-C REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.900 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21067 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.200 REMARK 200 RESOLUTION RANGE LOW (A) : 99.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.5 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : 0.03400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 26.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.22 REMARK 200 COMPLETENESS FOR SHELL (%) : 54.7 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.22900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: REFINED STRUCTURE OF GLN18SEMET SELENOMETHIONINE REMARK 200 DERIVATIVE OF BBAT REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 29.18 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.74 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25% T-BUTANOL, 0.1M TRIS BUFFER, PH REMARK 280 8.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 19.46950 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 28.08600 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 19.46950 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 28.08600 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 141 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 147 LIES ON A SPECIAL POSITION. REMARK 375 HOH B 70 LIES ON A SPECIAL POSITION. REMARK 375 HOH D 88 LIES ON A SPECIAL POSITION. REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 LEU B 215 CA LEU B 215 CB 0.873 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PHE A 108 CB - CG - CD1 ANGL. DEV. = -4.4 DEGREES REMARK 500 ARG A 117 CD - NE - CZ ANGL. DEV. = 17.0 DEGREES REMARK 500 ARG A 117 NE - CZ - NH1 ANGL. DEV. = 4.2 DEGREES REMARK 500 LEU B 215 N - CA - CB ANGL. DEV. = -16.2 DEGREES REMARK 500 ARG B 217 NE - CZ - NH1 ANGL. DEV. = 3.7 DEGREES REMARK 500 ARG D 402 CD - NE - CZ ANGL. DEV. = 8.9 DEGREES REMARK 500 ARG D 417 NE - CZ - NH2 ANGL. DEV. = -3.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACE A 100 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACE B 200 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACE D 400 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACE C 300 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NH2 A 122 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NH2 B 222 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NH2 D 422 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NH2 C 322 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1SNA RELATED DB: PDB REMARK 900 RELATED ID: 1SNE RELATED DB: PDB DBREF 1SN9 A 100 122 PDB 1SN9 1SN9 100 122 DBREF 1SN9 B 200 222 PDB 1SN9 1SN9 200 222 DBREF 1SN9 C 300 322 PDB 1SN9 1SN9 300 322 DBREF 1SN9 D 400 422 PDB 1SN9 1SN9 400 422 SEQRES 1 A 23 ACE TYR ARG ILE DPR SER TYR ASP PHE DAL ASP GLU LEU SEQRES 2 A 23 ALA LYS LEU LEU ARG GLN ALA DBZ GLY NH2 SEQRES 1 B 23 ACE TYR ARG ILE DPR SER TYR ASP PHE DAL ASP GLU LEU SEQRES 2 B 23 ALA LYS LEU LEU ARG GLN ALA DBZ GLY NH2 SEQRES 1 C 23 ACE TYR ARG ILE DPR SER TYR ASP PHE DAL ASP GLU LEU SEQRES 2 C 23 ALA LYS LEU LEU ARG GLN ALA DBZ GLY NH2 SEQRES 1 D 23 ACE TYR ARG ILE DPR SER TYR ASP PHE DAL ASP GLU LEU SEQRES 2 D 23 ALA LYS LEU LEU ARG GLN ALA DBZ GLY NH2 MODRES 1SN9 DPR A 104 PRO D-PROLINE MODRES 1SN9 DAL A 109 ALA D-ALANINE MODRES 1SN9 DBZ A 120 ALA 3-(BENZOYLAMINO)-L-ALANINE MODRES 1SN9 DPR B 204 PRO D-PROLINE MODRES 1SN9 DAL B 209 ALA D-ALANINE MODRES 1SN9 DBZ B 220 ALA 3-(BENZOYLAMINO)-L-ALANINE MODRES 1SN9 DPR C 304 PRO D-PROLINE MODRES 1SN9 DAL C 309 ALA D-ALANINE MODRES 1SN9 DBZ C 320 ALA 3-(BENZOYLAMINO)-L-ALANINE MODRES 1SN9 DPR D 404 PRO D-PROLINE MODRES 1SN9 DAL D 409 ALA D-ALANINE MODRES 1SN9 DBZ D 420 ALA 3-(BENZOYLAMINO)-L-ALANINE HET ACE A 100 3 HET DPR A 104 7 HET DAL A 109 5 HET DBZ A 120 14 HET NH2 A 122 2 HET ACE B 200 3 HET DPR B 204 7 HET DAL B 209 5 HET DBZ B 220 14 HET NH2 B 222 2 HET ACE C 300 3 HET DPR C 304 7 HET DAL C 309 5 HET DBZ C 320 14 HET NH2 C 322 1 HET ACE D 400 3 HET DPR D 404 7 HET DAL D 409 5 HET DBZ D 420 14 HET NH2 D 422 1 HETNAM ACE ACETYL GROUP HETNAM DPR D-PROLINE HETNAM DAL D-ALANINE HETNAM DBZ 3-(BENZOYLAMINO)-L-ALANINE HETNAM NH2 AMINO GROUP FORMUL 1 ACE 4(C2 H4 O) FORMUL 1 DPR 4(C5 H9 N O2) FORMUL 1 DAL 4(C3 H7 N O2) FORMUL 1 DBZ 4(C10 H12 N2 O3) FORMUL 1 NH2 4(H2 N) FORMUL 5 HOH *118(H2 O) HELIX 1 1 ASP A 107 DBZ A 120 1 14 HELIX 2 2 ASP B 207 ALA B 219 1 13 HELIX 3 3 PHE C 308 DBZ C 320 1 13 HELIX 4 4 PHE D 408 GLY D 421 1 14 SHEET 1 A 2 ARG C 302 ILE C 303 0 SHEET 2 A 2 TYR C 306 ASP C 307 -1 O TYR C 306 N ILE C 303 SHEET 1 B 2 ARG D 402 ILE D 403 0 SHEET 2 B 2 TYR D 406 ASP D 407 -1 O TYR D 406 N ILE D 403 LINK C ACE A 100 N TYR A 101 1555 1555 1.33 LINK C ILE A 103 N DPR A 104 1555 1555 1.33 LINK C DPR A 104 N SER A 105 1555 1555 1.33 LINK C PHE A 108 N DAL A 109 1555 1555 1.33 LINK C DAL A 109 N ASP A 110 1555 1555 1.34 LINK C ALA A 119 N DBZ A 120 1555 1555 1.32 LINK C DBZ A 120 N AGLY A 121 1555 1555 1.33 LINK C DBZ A 120 N BGLY A 121 1555 1555 1.33 LINK C BGLY A 121 N BNH2 A 122 1555 1555 1.33 LINK C AGLY A 121 N ANH2 A 122 1555 1555 1.33 LINK C ACE B 200 N TYR B 201 1555 1555 1.34 LINK C ILE B 203 N DPR B 204 1555 1555 1.33 LINK C DPR B 204 N SER B 205 1555 1555 1.34 LINK C PHE B 208 N DAL B 209 1555 1555 1.33 LINK C DAL B 209 N ASP B 210 1555 1555 1.34 LINK C ALA B 219 N DBZ B 220 1555 1555 1.32 LINK C DBZ B 220 N AGLY B 221 1555 1555 1.33 LINK C DBZ B 220 N BGLY B 221 1555 1555 1.32 LINK C AGLY B 221 N ANH2 B 222 1555 1555 1.33 LINK C BGLY B 221 N BNH2 B 222 1555 1555 1.33 LINK C ACE C 300 N TYR C 301 1555 1555 1.35 LINK C ILE C 303 N DPR C 304 1555 1555 1.33 LINK C DPR C 304 N SER C 305 1555 1555 1.33 LINK C PHE C 308 N DAL C 309 1555 1555 1.32 LINK C DAL C 309 N ASP C 310 1555 1555 1.32 LINK C ALA C 319 N DBZ C 320 1555 1555 1.34 LINK C DBZ C 320 N GLY C 321 1555 1555 1.34 LINK C GLY C 321 N NH2 C 322 1555 1555 1.35 LINK C ACE D 400 N TYR D 401 1555 1555 1.33 LINK C ILE D 403 N DPR D 404 1555 1555 1.33 LINK C DPR D 404 N SER D 405 1555 1555 1.33 LINK C PHE D 408 N DAL D 409 1555 1555 1.34 LINK C DAL D 409 N ASP D 410 1555 1555 1.35 LINK C ALA D 419 N DBZ D 420 1555 1555 1.33 LINK C DBZ D 420 N GLY D 421 1555 1555 1.32 LINK C GLY D 421 N NH2 D 422 1555 1555 1.33 SITE 1 AC1 4 ARG A 102 DAL A 109 HOH A 130 HOH A 143 SITE 1 AC2 2 HOH B 62 HOH B 70 SITE 1 AC3 3 HOH D 11 HOH D 69 HOH D 91 SITE 1 AC4 1 HOH C 22 SITE 1 AC5 5 ARG A 117 GLY A 121 HOH C 28 HOH A 144 SITE 2 AC5 5 HOH A 145 SITE 1 AC6 4 ARG B 217 DBZ B 220 GLY B 221 HOH B 31 SITE 1 AC7 3 DBZ D 420 GLY D 421 HOH D 34 SITE 1 AC8 1 GLY C 321 CRYST1 38.939 56.172 32.320 90.00 90.00 90.00 P 21 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.025681 0.000000 0.000000 0.00000 SCALE2 0.000000 0.017802 0.000000 0.00000 SCALE3 0.000000 0.000000 0.030941 0.00000 HETATM 1 C ACE A 100 16.360 16.333 0.739 1.00 23.74 C ANISOU 1 C ACE A 100 2065 3414 3540 722 -167 -140 C HETATM 2 O ACE A 100 16.464 17.469 1.233 1.00 24.47 O ANISOU 2 O ACE A 100 1983 3754 3560 -334 220 -347 O HETATM 3 CH3 ACE A 100 17.385 15.254 0.992 1.00 31.33 C ANISOU 3 CH3 ACE A 100 2996 5197 3713 1966 414 1088 C